Tumor-Vasculature-on-a-Chip for Investigating Nanoparticle Extravasation and Tumor Accumulation
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Nanoparticle tumor accumulation relies on a key mechanism, the enhanced permeability and retention (EPR) effect, but it remains challenging to decipher the exact impact of the EPR effect. Animal models in combination with imaging modalities are useful, but it is impossible to delineate the roles of multiple biological barriers involved in nanoparticle tumor accumulation. Here we report a microfluidic tumor-vasculature-on-a-chip (TVOC) mimicking two key biological barriers, namely, tumor leaky vasculature and 3D tumor tissue with dense extracellular matrix (ECM), to study nanoparticle extravasation through leaky vasculature and the following accumulation in tumor tissues. Intact 3D tumor vasculature was developed with selective permeability of small molecules (20 kDa) but not large ones (70 kDa). The permeability was further tuned by cytokine stimulation, demonstrating the independent control of the leaky tumor vasculature. Combined with tumor spheroids in dense ECM, our TVOC model is capable of predicting nanoparticles' in vivo tumor accumulation, thus providing a powerful platform for nanoparticle evaluation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Micro fl uidic studies using linear channels have also shown that use of coculture devices to screen NPs and determine optimal properties such as size, shape, and surface charge may be translated to in vivo tumor models 27”
From Rapid Assessment of Nanoparticle Extravasation in a Microfluidic Tumor Model (2019) · cites this paper as [27]
In the citing paper
“The microfluidic channel replicates an intact vascular structure surrounding the tumor that have a junction gap of ∼2 µm [48].”
Citations
Cites
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Fabrication of microfluidic systems in poly(dimethylsiloxane)
McDonald, J. C., Duffy, D. C., Anderson, J. R., Chiu, D. T., Wu, H., Schueller, O. J. A., & Whitesides, G. M. (2000) · Electrophoresis · doi:10.1002/(sici)1522-2683(20000101)21:1<27::aid-elps27>3.0.co;2-c · Cited by 3,329
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180
Nanoparticle-based targeted drug delivery
Singh, R., & Lillard, J. W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.12.004 · Cited by 2,734
Maeda, H., Nakamura, H., & Fang, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.002 · Cited by 2,376
Tumor delivery of macromolecular drugs based on the EPR effect
Torchilin, V. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.011 · Cited by 2,032
Exploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846
Openings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
Parodi, A., Quattrocchi, N., van de Ven, A. L., Chiappini, C., Evangelopoulos, M., Martinez, J. O., Brown, B. S., Khaled, S. Z., Yazdi, I. K., Enzo, M. V., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.212 · Cited by 1,168
Research works printed but not linked: 1
- Fox, 2006, Human Physiology, 501
Cited by
Items 101–160 of 160
3D spheroid-microvasculature-on-a-chip for tumor-endothelium mechanobiology interplay
Zhang, Y., Jiang, F., Zhao, Y. C., Cho, A., Fang, G., Cox, C. D., Zreiqat, H., Lu, Z. F., Lu, H., & Ju, L. A. (2023) · Biomedical Materials · doi:10.1088/1748-605x/ace7a4 · Cited by 15
Li, W., Wang, H., Li, Z., Wang, T., & Zhao, C. (2019) · Chemical Engineering Science · doi:10.1016/j.ces.2019.115155 · Cited by 14
Self-citationImpact of hydrogel biophysical properties on tumor spheroid growth and drug response
Cameron, A. P., Gao, S., Liu, Y., & Zhao, C. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213421 · Cited by 14
Self-citationMicrofluidic Reconstitution of Tumor Microenvironment for Nanomedical Applications
Oh, H. J., Kim, J., Kim, H., Choi, N., & Chung, S. H. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202002122 · Cited by 13
Targeted Cancer Therapy‐on‐A‐Chip
Abed, H., Radha, R., Anjum, S., Paul, V., AlSawaftah, N., Pitt, W. G., Ashammakhi, N. A., & Husseini, G. A. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400833 · Cited by 13
The promise of Synovial Joint-on-a-Chip in rheumatoid arthritis
Zhang, X., Su, R., Wang, H., Wu, R., Fan, Y., Bin, Z., Gao, C., & Wang, C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1408501 · Cited by 13
Self-citationA Molecular View of Lipid Nanoparticles: Insights into their Morphology and Structural Plasticity
Porte, S., Vadhana, V., & Sengupta, D. (2025) · Small · doi:10.1002/smll.202505404 · Cited by 16
Ugrinic, M., Decanini, D., Bidan, N., Lazzari, G., Harouri, A., Hwang, G., Haghiri‐Gosnet, A., & Mura, S. (2022) · Microelectronic Engineering · doi:10.1016/j.mee.2022.111898 · Cited by 13
Lu, R., Lee, B. J., & Lee, E. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.4c01005 · Cited by 12
Microfabricated Organ-Specific Models of Tumor Microenvironments
Oh, J. M., Park, Y., Lee, J., & Shen, K. (2025) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-110222-103522 · Cited by 10
Utilizing Nanomaterials in Microfluidic Devices for Disease Detection and Treatment
Tian, Z., Fu, Y., Dang, Z., Guo, T., Li, W., & Zhang, J. (2025) · Nanomaterials · doi:10.3390/nano15060434 · Cited by 10
“…a microfluidic tumor vasculature-on-a-chip (TVOC) (Figure 7D) to simulate the leaky characteristics of tumor vasculature and the dense extracellular matrix (ECM) of 3D ovarian tumor tissue, aiming to investigate the passage and accumulation of NPs through tumor vasculature and within tumors [106].”
Integration of Genomic Profiling and Organoid Development in Precision Oncology
Yoon, H., & Lee, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010216 · Cited by 11
Biosafety risk assessment of gold and aluminum nanoparticles in tumor-bearing mice
Zhu, G., Li, Z., Zhang, Y., Meng, X., Guan, M., Hu, Z., Yang, Y., Liu, K., & Sun, T. (2023) · APL Bioengineering · doi:10.1063/5.0144481 · Cited by 8
Surendran, V., Safarulla, S., Griffith, C. M., Ali, R., Madan, A., Polacheck, W. J., & Chandrasekaran, A. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c01766 · Cited by 9
Biomaterials meet organ-on-chips – a perspective on tumor modeling
Monteiro, C. F., Deus, I. A., Custódio, C. A., & Mano, J. F. (2024) · International Materials Reviews · doi:10.1177/09506608241303436 · Cited by 10
Boinapalli, Y., Pandey, R. S., Chauhan, A. S., & Sudheesh, M. S. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122579 · Cited by 9
Lu, J., Huang, Y., Hu, S., Xuzhan, L., Huang, Y., Wu, B., Zhao, C., Huang, J., Tan, B., Zhao, B., et al. (2026) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2026.118791 · Cited by 7
Self-citationChen, Y., Xue, Y., Xu, L., Li, W., Chen, Y., Zheng, S., Dai, R., & Liu, J. (2022) · Lab on a Chip · doi:10.1039/d2lc00631f · Cited by 6
Carton, F., & Malatesta, M. (2022) · European Journal of Histochemistry · doi:10.4081/ejh.2022.3603 · Cited by 6
Yang, G., Liu, Y., Hui, Y., Tengjisi, Chen, D., Weitz, D. A., & Zhao, C. (2021) · Angewandte Chemie · doi:10.1002/ange.202101730 · Cited by 6
Self-citationThe promising path of Oral MOFs: Redefining strategies for gastrointestinal detoxification
Quan, Y., Wu, Y., Wang, K., Ren, H., Zhang, G., Zhao, Y., & Miao, Y. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217168 · Cited by 6
Nanovaccines in gastrointestinal cancers
Wang, Y., Huang, P., Li, C., Tu, S., & Yang, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1680053 · Cited by 5
Jozani, K. A., Shen, K., Anvari, N., Hocevar, D., Jiang, R., Zhang, B., Yakavets, I., & Zhao, Y. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115835 · Cited by 8
Wu, X., Guo, H., Zhao, J., Wei, Y., Li, Y., & Pang, H. (2022) · Advanced Therapeutics · doi:10.1002/adtp.202200173 · Cited by 4
Gao, Y., Zhu, J., Zheng, X., Lin, G., & Miao, P. (2024) · Langmuir · doi:10.1021/acs.langmuir.4c04194 · Cited by 5
Synergy of Microfluidics and Nanomaterials: A Revolutionary Approach for Cancer Management
Pramoda, G., Singh, M., Gupta, P. K., & Shukla, R. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c00123 · Cited by 6
Polymeric Nanoparticles for Theranostic Treatment of Cancer
de Freitas, C. F., Tessaro, A. L., & Pellosi, D. S. (2022) · Springer eBooks · doi:10.1007/978-981-16-7152-4_6 · Cited by 3
Investigation of nanoparticle extravasation pathways in tumor vessel-on-a-chip devices
Dávila, S., Martín–Asensio, A., Diego, E. S., Hernández, J. J., & Rodríguez, I. (2025) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2025.102863 · Cited by 4
Microphysiological systems for metastasis research: a stepwise approach
Sharko, V., Ochoa, I., & Solanas, E. (2025) · Cellular Oncology · doi:10.1007/s13402-025-01110-4 · Cited by 5
“Notably, this increased permeability can be strategically exploited in nanomedicine to selectively deliver therapeu - tic agents to the TME, maximizing treatment efficacy while minimizing systemic toxicity, a phenomenon known as the enhanced permeability and retention (EPR) [ 134, 135].”
Martín–Asensio, A., Pardo, I. L., Mesa, R., Pardo, D., Fernandéz‐Blázquez, J. P., Martínez-Guil, J. C., Castellanos, M., Hernández, J. J., Somoza, Á., & Rodríguez, I. (2024) · Micro and Nano Systems Letters · doi:10.1186/s40486-024-00213-1 · Cited by 4
“So far, most (if not all) of these studies have been performed using fluorescent NPs [21–23], as they allow us to visualize and track various transport processes within the microfluidic system.”
Luo, Q. F., Zhang, Z., Huang, M. L., Lin, G., Tanaka, M., Lepler, S. E., Guan, J., Siemann, D. W., & Tang, X. (2022) · PLoS ONE · doi:10.1371/journal.pone.0266098 · Cited by 3
Vasquez, I., Nash, L. L., Shahriar, M., Megahed, M., Cao-Xue, J., Leon, I. D., Xu, C., Bickel, U., Raghavan, S. A., & Srivastava, I. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.06.717945 · Cited by 3
Zheng, Y., Pan, Y., Wang, Z., et al. (2025) · Analytical Methods · doi:10.1039/d5ay01174d · Cited by 2
Melanoma treatment in the era of nanotechnology and precision medicine
da Cruz, A. F., Colella, F., Grasso, G., Onesto, V., Forciniti, S., Ortiz, B. B., Carnevali, F., Siciliano, A. C., Bove, R., dos Santos, J. G., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03851-8 · Cited by 5
“8c) [323].”
Sun, D., Chen, J. L., Luo, C., Zheng, Y., Wang, X., Guo, B., Weitz, D. A., & Chen, D. (2026) · Chemical Engineering Science · doi:10.1016/j.ces.2026.123557 · Cited by 2
Self-citationMicrofluidics: A versatile tool for developing, optimizing, and delivering nanomedicines
Tahir, N., Sharifi, F., Khan, T. A., Khan, M. M., Madni, A., & Rehman, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818627-5.00017-8 · Cited by 3
Pan, Y., Wang, Z., Yan, Z., Sun, H., Zhang, L., & Zhang, W. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c00993 · Cited by 2
Engineered model of tumor microenvironment for replicating intratumoral drug delivery
Besanjideh, M., Zarei, F., Rezaeian, M., & Shamloo, A. (2025) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2025.06.023 · Cited by 3
Colloidal Self‐assembly of Block Copolymers for Drug Loading and Controlled Release
Yang, G., Liu, Y., & Zhao, C. (2022) · Wiley eBooks · doi:10.1002/9783527828722.ch13 · Cited by 2
Self-citationAlkhadrawi, H., Dese, K., Panchal, D. M., Pueschel, A. R., Freshwater, K. A., Stewart, A. B., Henderson, H., Elkins, M., Dave, R. T., Wilson, H., et al. (2024) · AIChE Journal · doi:10.1002/aic.18638 · Cited by 1
Hwang, H. W., Kim, S., Hwang, H., Han, H., Jeon, H., Kim, Y.-C., Lee, H., Sun, J., & Ok, M. (2022) · ACS Applied Nano Materials · doi:10.1021/acsanm.2c01936 · Cited by 1
Microfluidics and Cancer Treatment: Emerging Concept of Biomedical Engineering
Tawade, P. V., & Tondapurkar, N. (2023) · Biological and medical physics, biomedical engineering · doi:10.1007/978-981-19-9786-0_15 · Cited by 2
Wang, Y., Shang, W., Xiong, J., Liu, Y., Luo, T., Qi, X., Niu, M., & Xu, K. (2021) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2021.3124 · Cited by 1
Self-citationBazban‐Shotorbani, S., Gavins, F. N. E., Kant, K., Dufva, M., & Kamaly, N. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100092 · Cited by 1
Bazban‐Shotorbani, S., Gavins, F. N. E., Dufva, M., & Kamaly, N. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.09.443301
Axons-on-a-Chip for Mimicking Non-Disruptive Diffuse Axonal Injury underlying Traumatic Brain InjuryPreprint
Li, W., Wang, H., Pan, X., Gagoski, D., Durisic, N., Li, Z.-Y., Zhao, C.-X., & Wang, T. (2021) · bioRxiv · doi:10.1101/2021.05.06.442958 · Cited by 4
Self-citationAhmed-Cox, A., Pandžić, E., Johnston, S. T., Heu, C., McGhee, J. B., Mansfeld, F. M., Crampin, E. J., Davis, T. P., Whan, R. M., & Kavallaris, M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.26.465839
“Multidisciplinary studies to better evaluate how nanoparticle designs affect biocompatibility, 28 circulation, extravasation and drug efficacy have been a key focus in recent years [5-8].”
BackgroundOrgan on a chip in nanotechnology
Świst-Szulik, K. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13782-2.00032-2
Antibody-conjugated lipid nanoparticles as a targeted drug delivery system for hydrophobic drugs
Govardhan, S. A., Balki, S., Panda, E. S., Balaji, P. G., Gautam, A. S., Yadav, A. K., & Singh, R. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33382-8.00005-4
Hyung, S., Ko, J., An, M., Kim, S. T., Park, S. H., Hong, J. Y., Lim, S. H., Kim, K., & Lee, J. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb00577a
Wu, S., Li, W., Yang, Q., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04325-1
“This observation may be attributed to limitations of the enhanced permeability and retention (EPR) effect imposed by tumor-associated biological barriers, including leaky but heterogeneous vascular endothelium and a dense extracellular matrix (ECM) [26].”
Chong, Z., Tang, H., Zhang, Y., Ouyang, J., Zhu, J., Chen, Z., Liu, X., & Gu, Z. (2026) · Biomedical Materials · doi:10.1088/1748-605x/ae722d
Qin, X., Zhao, Y., Wu, Y., Efelis, A., Paul, R., Islam, K., Marquez, C. S., Liu, Y., & Liu, Y. (2026) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c01908
Self-citationKirbus, K., Kolar, J., Krebs, Č., Kocbek, P., & Žiberna, L. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27115018
“This is especially important for in vitro studies of the vasculature and microvasculature to mimic in vivo conditions where endothelial cells are continuously exposed to shear stress [4–6].”
Sharma, R. K., Singh, A. K., & Sagar, N. A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36532-4.00001-8
Ma, F., 刘少壮, Xiao, Q., Tang, B., Khan, M. A., & Pan, Q. (2026) · Industrial Crops and Products · doi:10.1016/j.indcrop.2026.123965
Mesenchymal stem cell-derived liver-on-a-chip reconstitutes human liver structure and function
Brooks, A., Yang, H., Barkauskas, D. S., Ranaweera, S., Zou, D., Goh, S., Ruan, Q., Bridle, K. R., Crawford, D. H., Liu, X., et al. (2026) · Cell Reports Methods · doi:10.1016/j.crmeth.2026.101545
Self-citationНиколаевич, К. А., Krasnoselskaya, E. N., Khanova, A. R., & Николаевич, Ф. С. (2026) · Biomaterials Advances · doi:10.1016/j.bioadv.2026.215141
Kang, S. J., Bong, S. H., Jo, M. J., Lee, J. M., Yoon, M. S., Park, S., Lee, Y., Shin, Y., Lee, H. J., Park, C., et al. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18091117 · Cited by 1
“Time-resolved measurements of fluorescently labeled compounds or surrogate tracers allow reconstruction of concentration gradients as they evolve under perfusion conditions [93,94].”
Metadata
- Authors
- Wang, H.-F., Ran, R., Liu, Y., Hui, Y., Zeng, B., Chen, D., Weitz, D. A., & Zhao, C.-X.
- Affiliations
- The University of Queensland , , , ,
- The University of Queensland (AU)
- State Key Laboratory Fluid Power and Mechatronic Systems (CN)
- Harvard University (US)
- Corresponding author
- Zhao, Chun-Xia
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-10-31
- Volume
- 12
- Issue
- 11
- Pages
- 11600-11609
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2899310002
- Semantic Scholar
- 8272278fc82b83ca8565e0af6d93c644e83995ed
- Cited by
- 161
- References
- 48
- Citations by year
- 2026: 14 · 2025: 19 · 2024: 20 · 2023: 24 · 2022: 30 · 2021: 23 · 2020: 18 · 2019: 13
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- ACS Nano (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Biomedical Imaging and Bioengineering (R01EB014703)
- Australian Research Council (FT140100726)
- Division of Materials Research (DMR-1420570, DMR-1708729)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Keywords
- nanoparticle extravasation, tumor accumulation, enhanced permeability and retention effect, extracellular matrix, tumor spheroids, microfluidic model, nanoparticle drug delivery
- MeSH terms
- Animals, Extracellular Matrix, Female, Fluorescent Dyes, Humans, Mice, Inbred BALB C, Mice, Nude, Neoplasms, Tissue Distribution, Mice, Nanoparticles, Lab-On-A-Chip Devices, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.